1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow Ustekinumab IV Infusion: new trials by email Literature Review of Ustekinumab IV Infusion trials Research Report on Ustekinumab IV Infusion
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative Colitis Ustekinumab IV Infusion, Ustekinumab SC Injection, Midazolam 2 mg - Crohn Disease, Ulcerative Colitis | Phase 1 | Terminated | Janssen Research & Development, LLC | 28 | 2018-02-02 | 2025-08-21 |
Colitis, Ulcerative (1) · Crohn Disease (1)
Janssen Research & Development, LLC (1)
Belgium (1) · Germany (1) · United Kingdom (1) · United States (1)
2017 (1)